{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:23:09Z","timestamp":1787998989664,"version":"build-2784847793"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>To longitudinally assesses pulmonary involvement in newly diagnosed rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients over a 12-months follow-up. To identify biomarkers and establish a diagnostic algorithm for monitoring pulmonary changes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Newly diagnosed RA and PsA patients were examined with clinical and laboratory assessments, pulmonary function tests (PFT), and chest radiography (CXR) at three-months intervals for one year.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The study enrolled 50 patients (26 RA, 24 PsA) and 26 controls. At baseline, 37.0% of arthritis patients (50.0% RA, 22.7% PsA) exhibited radiographic pulmonary involvement, with 64.7% being asymptomatic. No association was observed between CXR and PFTs. Reduced pathological breathing width was noted in 64.0% of patients (RA 69.2%, PsA 58.3%) and 23.1% of controls (<jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001). Thoracic excursion and lung auscultation showed no differences. During follow-up, PFT and physical examination findings remained stable. Mean CRP levels significantly decreased in RA patients from 23.5\u00a0mg\/l (\u00b1\u200933.6; 95% CI: 9.9\u201337.1) to 2.7\u00a0mg\/L (\u00b1\u20093.4; 95% CI: 1.0-4.3), and in PsA patients from 13.3\u00a0mg\/L (\u00b1\u200918.0; 95% CI: 5.7\u201320.9) to 8.1\u00a0mg\/L (\u00b1\u200916.2; 95% CI: 0.1\u201316.2) (<jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001). Additionally, significant reductions in disease activity scores and improvements in six-minute walking distance were observed (<jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001). No associations were identified between PFT outcomes, disease activity, or rheumatological medications throughout the disease course.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our study underscores the prevalence of significant, predominantly asymptomatic pulmonary involvement in newly diagnosed RA and PsA patients. The lack of correlation between pulmonary function, disease activity, and medication during disease progression suggests that reducing arthritic disease activity does not necessarily mitigate the risk or severity of pulmonary involvement. Finally, our finding underscore the need for more sensitive biomarkers and optimized monitoring strategies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00296-024-05751-w","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T12:06:33Z","timestamp":1734523593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pulmonary involvement in newly diagnosed and untreated rheumatoid arthritis and psoriatic arthritis: a prospective longitudinal study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9537-9659","authenticated-orcid":false,"given":"Lone","family":"Winter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4686-1143","authenticated-orcid":false,"given":"Simon M.","family":"Petzinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2377-5936","authenticated-orcid":false,"given":"Dirk","family":"Skowasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2386-4325","authenticated-orcid":false,"given":"Carmen","family":"Pizarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4100-9522","authenticated-orcid":false,"given":"Marcel","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6520-1020","authenticated-orcid":false,"given":"Daniel","family":"K\u00fctting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9310-3804","authenticated-orcid":false,"given":"Charlotte","family":"Behning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3152-6550","authenticated-orcid":false,"given":"Claus-J\u00fcrgen","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6591-5936","authenticated-orcid":false,"given":"Valentin S.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"5751_CR1","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1136\/ard.62.8.722","volume":"62","author":"C Turesson","year":"2003","unstructured":"Turesson C, O\u2019Fallon WM, Crowson CS et al (2003) Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 62:722\u2013727. https:\/\/doi.org\/10.1136\/ard.62.8.722","journal-title":"Ann Rheum Dis"},{"key":"5751_CR2","first-page":"62","volume":"29","author":"C Turesson","year":"2002","unstructured":"Turesson C, O\u2019Fallon WM, Crowson CS et al (2002) Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rhuematol 29:62\u201367","journal-title":"J Rhuematol"},{"key":"5751_CR3","doi-asserted-by":"publisher","first-page":"102776","DOI":"10.1016\/j.autrev.2021.102776","volume":"20","author":"FA Figus","year":"2021","unstructured":"Figus FA, Piga M, Azzolin I et al (2021) Rheumatoid arthritis: Extra-articular manifestations and comorbidities. Autoimmun rev 20:102776. https:\/\/doi.org\/10.1016\/j.autrev.2021.102776","journal-title":"Autoimmun rev"},{"key":"5751_CR4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.berh.2016.10.004","volume":"30","author":"C Kelly","year":"2016","unstructured":"Kelly C, Iqbal K, Iman-Gutierrez L et al (2016) Lung involvement in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 30:870\u2013888. https:\/\/doi.org\/10.1016\/j.berh.2016.10.004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"5751_CR5","first-page":"1","volume-title":"Lung Disease in Rheumatoid Arthritis","author":"S West","year":"2018","unstructured":"West S (2018) Clinical Overview of Rheumatoid Arthritis. Lung Disease in Rheumatoid Arthritis. Humana, Cham, pp 1\u201318"},{"key":"5751_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","volume":"25","author":"A Bilgici","year":"2005","unstructured":"Bilgici A, Ulusoy H, Kuru O et al (2005) Pulmonary involvement in rheumatoid arthritis. Rheumatol Int 25:429\u2013435. https:\/\/doi.org\/10.1007\/s00296-004-0472-y","journal-title":"Rheumatol Int"},{"key":"5751_CR7","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1136\/annrheumdis-2018-213286","volume":"77","author":"B Michelsen","year":"2018","unstructured":"Michelsen B, Uhlig T, Sexton J et al (2018) Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls. Ann Rheum Dis 77:1290\u20131294. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213286","journal-title":"Ann Rheum Dis"},{"key":"5751_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-319-68888-6_4","volume-title":"Lung Disease in Rheumatoid Arthritis","author":"M Kristen Demoruelle","year":"2018","unstructured":"Kristen Demoruelle M, Olson AL, Solomon JJ (2018) The Epidemiology of Rheumatoid Arthritis-Associated Lung Disease. Lung Disease in Rheumatoid Arthritis. Humana, Cham, pp 45\u201358"},{"key":"5751_CR9","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz T, Nannini C, Medina-Velasquez YF et al (2010) Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthr Rhuem 62:1583\u20131591. https:\/\/doi.org\/10.1002\/art.27405","journal-title":"Arthr Rhuem"},{"key":"5751_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","volume":"183","author":"AL Olson","year":"2011","unstructured":"Olson AL, Swigris JJ, Sprunger DB et al (2011) Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med 183:372\u2013378. https:\/\/doi.org\/10.1164\/rccm.201004-0622OC","journal-title":"Am J Respir Crit Care Med"},{"key":"5751_CR11","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.3899\/jrheum.150166","volume":"42","author":"FAG Pinheiro","year":"2015","unstructured":"Pinheiro FAG, Souza DCC, Sato EI (2015) A Study of Multiple Causes of Death in Rheumatoid Arthritis. J Rhuematol 42:2221\u20132228. https:\/\/doi.org\/10.3899\/jrheum.150166","journal-title":"J Rhuematol"},{"key":"5751_CR12","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ccm.2019.05.003","volume":"40","author":"AJ Esposito","year":"2019","unstructured":"Esposito AJ, Chu SG, Madan R et al (2019) Thoracic Manifestations of Rheumatoid Arthritis. Clin Chest Med 40:545\u2013560. https:\/\/doi.org\/10.1016\/j.ccm.2019.05.003","journal-title":"Clin Chest Med"},{"key":"5751_CR13","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s00296-024-05685-3","volume":"44","author":"VS Sch\u00e4fer","year":"2024","unstructured":"Sch\u00e4fer VS, Winter L, Skowasch D et al (2024) Exploring pulmonary involvement in newly diagnosed rheumatoid arthritis, and psoriatic arthritis: a single center study. Rheumatol Int 44:1975\u20131986. https:\/\/doi.org\/10.1007\/s00296-024-05685-3","journal-title":"Rheumatol Int"},{"key":"5751_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2174\/1573397116666200905122757","volume":"17","author":"D Dejcman","year":"2021","unstructured":"Dejcman D, Skowasch D, Pizarro C et al (2021) Pulmonary Manifestations of Rheumatoid Arthritis, Psoriatic Arthritis and Peripheral Spondyloarthritis: Prevalence, Diagnostic Approach and Treatment Options. Curr Rheumatol Rev 17:17\u201328. https:\/\/doi.org\/10.2174\/1573397116666200905122757","journal-title":"Curr Rheumatol Rev"},{"key":"5751_CR15","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1080\/13543784.2024.2376567","volume":"33","author":"M Sebastiani","year":"2024","unstructured":"Sebastiani M, Manfredi A, Croci S et al (2024) Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs. Expert Opin Investig Drugs 33:815\u2013827. https:\/\/doi.org\/10.1080\/13543784.2024.2376567","journal-title":"Expert Opin Investig Drugs"},{"key":"5751_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/09059180.00008014","volume":"24","author":"M Shaw","year":"2015","unstructured":"Shaw M, Collins BF, Ho LA et al (2015) Rheumatoid arthritis-associated lung disease. Eur Respiratory Rev 24:1\u201316. https:\/\/doi.org\/10.1183\/09059180.00008014","journal-title":"Eur Respiratory Rev"},{"key":"5751_CR17","doi-asserted-by":"publisher","unstructured":"Bendstrup E, M\u00f8ller J, Kronborg-White S et al (2019) Interstitial Lung Disease in Rheumatoid Arthritis Remains a Challenge for Clinicians. J Clin Med 8. https:\/\/doi.org\/10.3390\/jcm8122038","DOI":"10.3390\/jcm8122038"},{"key":"5751_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/03009740310004621","volume":"33","author":"C Turesson","year":"2004","unstructured":"Turesson C, Jacobsson LTH (2004) Epidemiology of extra-articular manifestations in rheumatoid arthritis. Scand J Rheumatol 33:65\u201372. https:\/\/doi.org\/10.1080\/03009740310004621","journal-title":"Scand J Rheumatol"},{"key":"5751_CR19","doi-asserted-by":"publisher","unstructured":"Albrecht K, Strangfeld A, Marschall U et al (2023) Interstitial lung disease in rheumatoid arthritis: incidence, prevalence and related drug prescriptions between 2007 and 2020. https:\/\/doi.org\/10.1136\/rmdopen-2022-002777. RMD Open 9","DOI":"10.1136\/rmdopen-2022-002777"},{"key":"5751_CR20","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","volume":"49","author":"G Koduri","year":"2010","unstructured":"Koduri G, Norton S, Young A et al (2010) Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (Oxford) 49:1483\u20131489. https:\/\/doi.org\/10.1093\/rheumatology\/keq035","journal-title":"Rheumatology (Oxford)"},{"key":"5751_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12890-023-02532-2","volume":"23","author":"M Xie","year":"2023","unstructured":"Xie M, Zhu C, Ye Y (2023) Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis. BMC Pulm Med 23:255. https:\/\/doi.org\/10.1186\/s12890-023-02532-2","journal-title":"BMC Pulm Med"},{"key":"5751_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jbspin.2018.03.016","volume":"86","author":"CI Da\u00efen","year":"2019","unstructured":"Da\u00efen CI, Tubery A, Beurai-Weber M et al (2019) Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases. Joint Bone Spine 86:49\u201354. https:\/\/doi.org\/10.1016\/j.jbspin.2018.03.016","journal-title":"Joint Bone Spine"},{"key":"5751_CR23","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1164\/ajrccm.157.5.9710018","volume":"157","author":"T Perez","year":"1998","unstructured":"Perez T, Remy-Jardin M, Cortet B (1998) Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings. Am J Respir Crit Care Med 157:1658\u20131665. https:\/\/doi.org\/10.1164\/ajrccm.157.5.9710018","journal-title":"Am J Respir Crit Care Med"},{"key":"5751_CR24","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1183\/09031936.97.10051072","volume":"10","author":"A Vergnen\u00e8gre","year":"1997","unstructured":"Vergnen\u00e8gre A, Pugnere N, Antonini MT et al (1997) Airway obstruction and rheumatoid arthritis. Eur Respir J 10:1072\u20131078. https:\/\/doi.org\/10.1183\/09031936.97.10051072","journal-title":"Eur Respir J"},{"key":"5751_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.38.3.222","volume":"38","author":"DM Geddes","year":"1979","unstructured":"Geddes DM, Webley M, Emerson PA (1979) Airways obstruction in rheumatoid arthritis. Ann Rheum Dis 38:222\u2013225. https:\/\/doi.org\/10.1136\/ard.38.3.222","journal-title":"Ann Rheum Dis"},{"key":"5751_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.hrtlng.2023.05.020","volume":"62","author":"Z Cao","year":"2023","unstructured":"Cao Z, Li Q, Wu J et al (2023) Causal association of rheumatoid arthritis with obstructive lung disease: Evidence from Mendelian randomization study. Heart Lung 62:35\u201342. https:\/\/doi.org\/10.1016\/j.hrtlng.2023.05.020","journal-title":"Heart Lung"},{"key":"5751_CR27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.4081\/mrm.2022.877","volume":"17","author":"A Ben Tekaya","year":"2022","unstructured":"Ben Tekaya A, Mokaddem S, Athimini S et al (2022) Risk factors for rheumatoid arthritis-associated interstitial lung disease: a retrospective study. Multidiscip Respir Med 17:877. https:\/\/doi.org\/10.4081\/mrm.2022.877","journal-title":"Multidiscip Respir Med"},{"key":"5751_CR28","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.semarthrit.2013.09.005","volume":"43","author":"C Roubille","year":"2014","unstructured":"Roubille C, Haraoui B (2014) Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum 43:613\u2013626. https:\/\/doi.org\/10.1016\/j.semarthrit.2013.09.005","journal-title":"Semin Arthritis Rheum"},{"key":"5751_CR29","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2021-0616-OA","author":"YM Butt","year":"2022","unstructured":"Butt YM, Smith ML, Tazelaar HD et al (2022) Surgical Pathology of Diffuse Parenchymal Lung Disease in Patients With Psoriasis or Psoriatic Arthritis. Arch Pathol Lab Med. https:\/\/doi.org\/10.5858\/arpa.2021-0616-OA","journal-title":"Arch Pathol Lab Med"},{"key":"5751_CR30","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s10067-014-2652-9","volume":"34","author":"R Peluso","year":"2015","unstructured":"Peluso R, Iervolino S, Vitiello M et al (2015) Extra-articular manifestations in psoriatic arthritis patients. Clin Rheumatol 34:745\u2013753. https:\/\/doi.org\/10.1007\/s10067-014-2652-9","journal-title":"Clin Rheumatol"},{"key":"5751_CR31","doi-asserted-by":"publisher","first-page":"874","DOI":"10.18553\/jmcp.2015.21.10.874","volume":"21","author":"SR Feldman","year":"2015","unstructured":"Feldman SR, Zhao Y, Shi L et al (2015) Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis. J Manag Care Spec Pharm 21:874\u2013888. https:\/\/doi.org\/10.18553\/jmcp.2015.21.10.874","journal-title":"J Manag Care Spec Pharm"},{"key":"5751_CR32","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s10067-011-1692-7","volume":"30","author":"M Khraishi","year":"2011","unstructured":"Khraishi M, MacDonald D, Rampakakis E et al (2011) Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts. Clin Rheumatol 30:877\u2013885. https:\/\/doi.org\/10.1007\/s10067-011-1692-7","journal-title":"Clin Rheumatol"},{"key":"5751_CR33","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1002\/art.1780401021","volume":"40","author":"K Wong","year":"1997","unstructured":"Wong K, Gladman DD, Husted J et al (1997) Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 40:1868\u20131872. https:\/\/doi.org\/10.1002\/art.1780401021","journal-title":"Arthritis Rheum"},{"key":"5751_CR34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ad.2016.04.018","volume":"107","author":"R Burgos-Pol","year":"2016","unstructured":"Burgos-Pol R, Mart\u00ednez-Sesmero JM, Ventura-Cerd\u00e1 JM et al (2016) Coste de la psoriasis y artritis psori\u00e1sica en cinco pa\u00edses de Europa: una revisi\u00f3n sistem\u00e1tica (The Cost of Psoriasis and Psoriatic Arthritis in 5 European Countries: A Systematic Review). Actas Dermosifiliogr 107:577\u2013590. https:\/\/doi.org\/10.1016\/j.ad.2016.04.018","journal-title":"Actas Dermosifiliogr"},{"key":"5751_CR35","first-page":"s238","volume":"22","author":"C Evans","year":"2016","unstructured":"Evans C (2016) Managed care aspects of psoriasis and psoriatic arthritis. Am J Manag Care 22:s238\u2013s243","journal-title":"Am J Manag Care"},{"key":"5751_CR36","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/art.42640","volume":"75","author":"G Koduri","year":"2023","unstructured":"Koduri G, Solomon JJ (2023) Identification, Monitoring, and Management of Rheumatoid Arthritis-Associated Interstitial Lung Disease. Arthritis Rheumatol (Hoboken N J) 75:2067\u20132077. https:\/\/doi.org\/10.1002\/art.42640","journal-title":"Arthritis Rheumatol (Hoboken N J)"},{"key":"5751_CR37","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthr Rhuem 62:2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584","journal-title":"Arthr Rhuem"},{"key":"5751_CR38","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665\u20132673. https:\/\/doi.org\/10.1002\/art.21972","journal-title":"Arthritis Rheum"},{"key":"5751_CR39","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.1093\/rheumatology\/kead027","volume":"62","author":"SH Chang","year":"2023","unstructured":"Chang SH, Lee JS, Ha Y-J et al (2023) Lung function trajectory of rheumatoid arthritis-associated interstitial lung disease. Rheumatology (Oxford) 62:3014\u20133024. https:\/\/doi.org\/10.1093\/rheumatology\/kead027","journal-title":"Rheumatology (Oxford)"},{"key":"5751_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.rdc.2014.12.004","volume":"41","author":"ZX Yunt","year":"2015","unstructured":"Yunt ZX, Solomon JJ (2015) Lung disease in rheumatoid arthritis. Rheum Dis Clin North Am 41:225\u2013236. https:\/\/doi.org\/10.1016\/j.rdc.2014.12.004","journal-title":"Rheum Dis Clin North Am"},{"key":"5751_CR41","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00330-003-2026-1","volume":"14","author":"J Biederer","year":"2004","unstructured":"Biederer J, Schnabel A, Muhle C et al (2004) Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur Radiol 14:272\u2013280. https:\/\/doi.org\/10.1007\/s00330-003-2026-1","journal-title":"Eur Radiol"},{"key":"5751_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5001\/omj.2009.20","volume":"24","author":"T Al-Assadi","year":"2009","unstructured":"Al-Assadi T, Al-Shemery A, Salman S (2009) Correlation of lung function with disease activity rheumatoid arthritis. Oman Med J 24:84\u201388. https:\/\/doi.org\/10.5001\/omj.2009.20","journal-title":"Oman Med J"},{"key":"5751_CR43","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5152\/eurjrheum.2019.19044","volume":"6","author":"H Dong","year":"2019","unstructured":"Dong H, Julien PJ, Demoruelle MK et al (2019) Interstitial lung abnormalities in patients with early rheumatoid arthritis: A pilot study evaluating prevalence and progression. Eur J Rheumatol 6:193\u2013198. https:\/\/doi.org\/10.5152\/eurjrheum.2019.19044","journal-title":"Eur J Rheumatol"},{"key":"5751_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.5152\/TurkThoracJ.2022.21263","volume":"23","author":"HW Abdelwahab","year":"2022","unstructured":"Abdelwahab HW, Shalabi NM, Rashad Ghoneim MM et al (2022) Screening for Subclinical Interstitial Lung Disease in Rheumatoid Arthritis Patients: Functional and Radiological Methods. Turkish Thorac J 23:261\u2013267. https:\/\/doi.org\/10.5152\/TurkThoracJ.2022.21263","journal-title":"Turkish Thorac J"},{"key":"5751_CR45","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1093\/rheumatology\/keac208","volume":"61","author":"R Brooks","year":"2022","unstructured":"Brooks R, Baker JF, Yang Y et al (2022) The impact of disease severity measures on survival in U.S. veterans with rheumatoid arthritis-associated interstitial lung disease. Rheumatology (Oxford) 61:4667\u20134677. https:\/\/doi.org\/10.1093\/rheumatology\/keac208","journal-title":"Rheumatology (Oxford)"},{"key":"5751_CR46","doi-asserted-by":"publisher","unstructured":"Sparks JA, He X, Huang J Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study., Arthritisrheumatology (, Hoboken et al (2019) N.J.) 71:1472\u20131482. https:\/\/doi.org\/10.1002\/art.40904","DOI":"10.1002\/art.40904"},{"key":"5751_CR47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.reumae.2021.12.003","volume":"19","author":"J Narv\u00e1ez","year":"2023","unstructured":"Narv\u00e1ez J, Aburto M, Seoane-Mato D et al (2023) Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology. Reumatol Clin 19:74\u201381. https:\/\/doi.org\/10.1016\/j.reumae.2021.12.003","journal-title":"Reumatol Clin"},{"key":"5751_CR48","doi-asserted-by":"publisher","unstructured":"Andronache I-T, \u015eu\u0163a V-C, \u015eu\u0163a M et al (2023) Better Safe than Sorry: Rheumatoid Arthritis, Interstitial Lung Disease, and Medication-A Narrative Review. https:\/\/doi.org\/10.3390\/biomedicines11061755. Biomedicines 11","DOI":"10.3390\/biomedicines11061755"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05751-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05751-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05751-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T06:38:19Z","timestamp":1737700699000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05751-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["5751"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05751-w","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"10 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and has been reviewed and approved by the ethics committee of the University Hospital Bonn, Germany (reference number: 209\/18). Written informed consent was obtained from every patient prior to inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Patients and\/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient and public involvement"}},{"value":"Informed consent was obtained from all subjects before enrollment.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"This manuscript is an original work and has not been published or submitted elsewhere, in part or in whole. A related publication addressed the baseline findings of this cohort: Sch\u00e4fer VS, Winter L, Skowasch D, et al. Exploring pulmonary involvement in newly diagnosed rheumatoid arthritis and psoriatic arthritis: A single-center study. Rheumatol Int. 2024 Oct;44(10):1975\u20131986. doi: . Epub 2024 Aug 21. PMID: 39167172; PMCID: PMC11392970.While the prior study focused on baseline examination results, the current manuscript presents a longitudinal analysis of follow-up data from the same cohort, specifically examining the progression of pulmonary involvement in patients with rheumatoid arthritis and psoriatic arthritis. A summary of baseline findings is included for contextual clarity, resulting in minor overlap with the previous publication. In cases of overlap, the prior study is appropriately cited to acknowledge its contribution.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Note on related congress abstracts and publication"}}],"article-number":"3"}}